Nicholas J Lawrence

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Radical Prostatectomy

Hematopoietic Stem Cell

Top Venues

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Shengyan Xiang, Kendall C Craig, Xingju Luo, Darcy L Welch, Renan B Ferreira, Harshani R Lawrence, Nicholas J Lawrence, Damon R Reed, Mark G Alexandrow
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function. Molecular cancer therapeutics (2024)
Shengyan Xiang, Kendall C Craig, Xingju Luo, Darcy L Welch, Renan B Ferreira, Harshani R Lawrence, Nicholas J Lawrence, Damon R Reed, Mark G Alexandrow
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function. Molecular cancer therapeutics (2024)
Shengyan Xiang, Kendall C Craig, Xingju Luo, Darcy L Welch, Renan B Ferreira, Harshani R Lawrence, Nicholas J Lawrence, Damon R Reed, Mark G Alexandrow
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function. Molecular cancer therapeutics (2024)
Mithila Sawant, Kiran Mahajan, Arun Renganathan, Cody Weimholt, Jingqin R Luo, Vandna Kukshal, Joseph M Jez, Myung Sik Jeon, Bo Zhang, Tiandao Li, Bin Fang, Yunting Luo, Nicholas J Lawrence, Harshani R Lawrence, Felix Y Feng, Nupam P Mahajan
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting. Science translational medicine 14 (649) (2022)
Joseph Pidala, Kelly Walton, Hany Elmariah, Jongphil Kim, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan G Faramand, Marco L Davila, Michael L Nieder, Elizabeth M Sagatys, Shernan G Holtan, Nicholas J Lawrence, Harshani R Lawrence, Bruce R Blazar, Claudio Anasetti, Said M Sebti, Brian C Betts
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Jeremy J McGuire, Jeremy S Frieling, Chen Hao Lo, Tao Li, Ayaz Muhammad, Harshani R Lawrence, Nicholas J Lawrence, Leah M Cook, Conor C Lynch
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nature communications 12 (1) (2021)